|
Home : Unsafe Drugs : Avandia : News Articles : Avandia Costs GSK $3.4 Billion - Pharmaceutical Technology Avandia Costs GSK $3.4 Billion - Pharmaceutical Technology
GlaxoSmithKline (GSK) is expecting to pay $3.4 billion to settle legal charges relating to its diabetes drug Avandia, as well as sales and promotional practices in the US for other products. The amount is in addition the $2.36-billion legal charges previously announced in ...
Avandia Case Evaluation Form
This form is secure and encrypted. More information about secure forms and your privacy here.
|




